Crispr Therapeutics shares owned by Bouvel Investment Partners
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bouvel Investment Partners
from 13F filings
Historical chart of Bouvel Investment Partners investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bouvel Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bouvel Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.5M | 22k | 68.16 |
| 2023-12-31 | $1.4M | 22k | 62.60 |
| 2023-09-30 | $949k | 21k | 45.39 |
| 2023-06-30 | $1.2M | 21k | 56.14 |
| 2023-03-31 | $903k | 20k | 45.23 |
| 2022-12-31 | $788k | 19k | 40.65 |
| 2022-09-30 | $1.2M | 19k | 65.36 |
| 2022-06-30 | $1.1M | 19k | 60.75 |
| 2022-03-31 | $1.1M | 18k | 62.75 |
| 2021-12-31 | $1.4M | 18k | 75.81 |
| 2021-09-30 | $2.1M | 18k | 111.92 |
| 2021-06-30 | $3.0M | 19k | 161.86 |
| 2021-03-31 | $2.3M | 19k | 121.85 |
| 2020-12-31 | $2.9M | 19k | 153.11 |
More positions owned by Bouvel Investment Partners
View all positions for Bouvel Investment Partners